ClinicalTrials.gg
RecruitingNCT06692569mCIMTUpdated Nov 18, 2024

The Effect of Modified Constraint Induced Movement Therapy on Upper Extremity Function in Stroke Rehabilitation

An interventional study of Conventional Physical Therapy and Modified Constraint Induced Movement Therapy in Stroke, Hemiplegia and Chronic Stroke Patients, sponsored by University of Jazan. Recruiting at 1 site in Saudi Arabia. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-11-18.

Sponsored by University of Jazan · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Stroke with a site in Saudi Arabia — 10 open to participants now, 11 under way, 1 of them phase 3. Stroke · Saudi Arabia.

Planned enrollment
18th of 27
34 · median 40
Started
2024
with 2 others
No phase
25 of 30
9 open now
Primary completion
2025-07
later than 4 of 10 live
Registered
21st of 30
by date
Lead sponsor
3 of 30
University of Jazan

Among the 30 studies in Stroke with a site in Saudi Arabia, this one is the 18th largest by planned enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2024, is one of 25 with no phase, reaches primary completion later than 4 of the 10 other live ones, and was the 21st registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

10 of the 30 studies in Stroke with a site in Saudi Arabia are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 45 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Stroke with a site in Saudi Arabia, or all of them as a file.
02

Study summary

The purpose of the study is to determine the effect of Modified Constraint-Induced Movement Therapy and trunk restraint contrasted with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.

  • To find out the effectiveness of conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
  • To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint along with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
  • To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint combined with conventional physical therapy treatment versus conventional physical therapy treatment alone on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
03

Conditions studied

  • Stroke
  • Hemiplegia
  • Chronic Stroke Patients

Keywords

  • stroke
  • hemiplegia
  • constraint induced movement therapy
  • modified constraint induced movement therapy
  • trunk restrain
  • upper extremity motor function
04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Right or left-sided chronic hemiplegic patients.
  • Onset of stroke More than six months.
  • Age between 45 to 65 years of both genders.
  • - Scored more than 24/30.
  • Modified Ashworth Scale for spasticity 1 or 1+.
  • Have at least 20° wrist active extension and at least 10° of metacarpophalangeal active extension of the paretic upper extremity.
  • Have at least grade 2/5 of muscle power on upper extremity especially in wrist extensors.
  • Have normal visual perception.
  • With no other neurological disorders.

Exclusion criteria

Exclusion Criteria:

  • Unable to follow visual and oral commands.
  • Unilateral neglect.
  • Severe cognitive, or language deficits.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
34 participants (estimated)

Study arms

  • Active comparator
    Control

    Conventional Physical Therapy

    Other: Conventional Physical Therapy

  • Experimental
    Experimental

    Conventional Physical Therapy and modified constraint induced movement therapy

    Other: Modified Constraint Induced Movement Therapy

Interventions

  • OtherConventional Physical Therapy

    The conventional Physical Therapy, the treatment will be based on the client's capabilities. It included functional reeducation, muscle strengthening and stretching, muscle tone regulation methods, and training for activities of daily living

  • OtherModified Constraint Induced Movement Therapy

    Modified Constraint Induced Movement Therapy (mCIMT) which involves trunk constraint along with conventional Physical Therapy treatment. Under the attentive guidance of a physiotherapist, the patient engages in specific hand activities aligned with personalized goals. These activities encompass tasks such as picking up marbles, flipping cards, stacking blocks, combing hair, writing, and other actions relevant to daily life. The difficulty level is dynamically adjusted according to the patient's abilities and progress during the training sessions.Tasks may vary from one patient to another, and each session introduces fresh, goal-oriented challenges to further enhance rehabilitation outcomes, along with the conventional physical therapy treatment. The patients were wearing a trunk west which had a Velcro strap on the non-effected side part of the west, and it was attached to the Velcro straps on the non-affected part on the back support of the treatment chair.

06

What researchers measure

Primary outcomes

  1. Wolf Motor Function Test

    Wolf Motor Function Test assessment tool was specifically developed to assess and evaluate the exercise capacity of individuals with varying degrees of upper extremity motion impairments, ranging from mild to severe, in both laboratory and clinical settings. It represents an enhancement over a previous tool that was more suitable for assessing high-functioning patients but posed challenges when used with individuals who had limited hand and finger mobility

    Time frame: Week 0 and week 6

  2. Berg Balance Scale

    The Berg Balance Scale (BBS) is a widely used clinical assessment tool designed to evaluate and quantify an individual's balance and stability during various tasks. It consists of a series of 14 tasks or activities that challenge balance and mobility, such as standing on one foot, reaching for objects, and turning in place. Each task is scored on a scale ranging from 0 to 4, with 0 indicating the lowest level of performance and 4 indicating the highest level of performance

    Time frame: week 0 and week 6

  3. Stroke Specific Quality of Life Scale

    Stroke Specific Quality of Life Scale (SS-QOL) is a specialized assessment tool designed to measure the quality of life in individuals who have experienced a stroke. This scale is specifically tailored to evaluate the impact of stroke on various aspects of a person's life, encompassing physical, psychological, and social domains. The SS-QOL questionnaire typically consists of multiple items or questions that cover a range of topics, including physical health, mobility, communication abilities, emotional well-being, and social relationships. Respondents rate their level of satisfaction or well-being in each domain, often on a scale from 0 to 5 or 0 to 100, with higher scores indicating better quality of life

    Time frame: week 0 and week 6

07

Study locations

1 of 1 sites recruiting
  • Majmaah Rehabilitation center
    Riyadh, Saudi Arabia
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Jul 2025, 8 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 8 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2024
First posted
Nov 18, 2024
StartActual
Nov 12, 2024
Primary completionEst.
Jul 13, 2025
CompletionEst.
Jul 13, 2025
Last update
Nov 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06692569
Lead sponsor
University of Jazan
Collaborators
Majmaah University
Responsible party
Karthick Balasubramanian (Lecturer, University of Jazan) — Principal investigator
First posted
Nov 18, 2024
Start date
Nov 12, 2024
Primary completion
Jul 13, 2025 (estimated)
Completion
Jul 13, 2025 (estimated)
Last update
Nov 18, 2024

Study contacts

Mohammed Mansour Al Shehri, PhD
Contact
moalshehri@jazanu.edu.sa
00966-503946253
Karthick BALASUBRAMANIAN, MPT
principal investigator · University of Jazan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion